US EditionJPMorgan U.S. Quality Factor ETF $JQUA Shares Acquired by D.A. Davidson & CO.
Pacer Advisors reduced its holdings in NiSource by 45.3% to $1.93 million in the third quarter, reflecting a significant portfolio adjustment.
- On Wednesday, October 29th, NiSource, Inc. reported $0.19 EPS for the quarter, missing the $0.20 consensus by $0.01 and posting $1.27 billion in revenue.
- Investor rebalancing across funds and institutions prompted several research firms to raise targets, with Evercore ISI at $47 and Jefferies Financial Group at $50, averaging $46.67.
- Other managers made offsetting moves as Pacer Advisors Inc. sold 36,839 shares reducing its stake by 45.3%, EVP Kimberly S. Cuccia sold 8,000 shares for $345,040, and Hantz Financial Services Inc. and Crewe Advisors LLC boosted holdings.
- Analyst consensus and price targets indicate a 'Moderate Buy' with a MarketBeat average price target of $46.67; shares opened at $41.79, with company insiders holding 0.24%.
- Looking ahead, the company's guidance shows FY2026 EPS at 2.020–2.07 and FY2025 EPS at 1.870–1.89, with 91.64% institutional ownership and recent holdings reports.
5 Articles
5 Articles
defenseworld.net
Financial Consulate Inc. Makes New Investment in Lockheed Martin Corporation $LMT
Financial Consulate Inc. bought a new position in Lockheed Martin Corporation (NYSE:LMT – Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 3,431 shares of the aerospace company’s stock, valued at approximately $1,713,000. A number of other large investors have also recently modified their holdings of the stock. Salomon & Ludwin LLC raised its stake in Lockheed Martin by 126.5% in the third qu…
AnaptysBio, Inc. $ANAB is HighMark Wealth Management LLC’s 10th Largest Position
HighMark Wealth Management LLC lowered its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) by 7.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 135,050 shares of the biotechnology company’s stock after selling 10,500 shares during the period. AnaptysBio makes up approximately 1.9% of HighMark […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
